OTCPicks Featured Article: Pfizer Acquires Encysive Pharmaceuticals, Inc. (ENCY) and Rights to Premium Drug
Pfizer is currently working on acquiring Encysive Pharmaceuticals, Inc., a publicly held biopharmaceutical company. Encysive developed a product called THELIN®, an oral, taken once daily endothelin - A receptor antagonist (ETRA), which is used for the treatment of pulmonary arterial hypertension (PAH). THELIN® is commercially available in much of the European Union and is approved in other markets. The company saw a rise of 110.19% on Wednesday. The agreed upon terms call for Pfizer to make a cash tender offer for all issued and outstanding shares of Encysive for $2.35 per share, which is conclusive to an equity value of…